Literature DB >> 32869845

Race, Ancestry, and Vitamin D Metabolism: The Multi-Ethnic Study of Atherosclerosis.

Simon Hsu1, Andrew N Hoofnagle2, Deepak K Gupta3,4, Orlando M Gutierrez5,6, Carmen A Peralta7,8,9, Steven Shea10,11, Norrina B Allen12, Gregory Burke13, Erin D Michos14,15, Joachim H Ix16,17, David Siscovick18, Bruce M Psaty19,20, Karol E Watson21, Bryan Kestenbaum1, Ian H de Boer1, Cassianne Robinson-Cohen22,23.   

Abstract

CONTEXT: A comprehensive characterization of racial/ethnic variations in vitamin D metabolism markers may improve our understanding of differences in bone and mineral homeostasis and the risk of vitamin D-related diseases.
OBJECTIVE: Describe racial/ethnic differences in vitamin D metabolism markers and their associations with genetic ancestry. DESIGN, SETTING, PARTICIPANTS: In a cross-sectional study within the Multi-Ethnic Study of Atherosclerosis (MESA), we compared a comprehensive panel of vitamin D metabolism markers across self-reported racial/ethnic groups of Black (N = 1759), White (N = 2507), Chinese (N = 788), and Hispanic (N = 1411). We evaluated associations of proportion African and European ancestry with this panel of markers in Black and Hispanic participants using ancestry informative markers. Latent class analysis evaluated associations between patterns of vitamin D measurements with race/ethnicity.
RESULTS: Compared with Black participants, White participants had significantly higher serum concentrations of 25-hydroxyvitamin D and fibroblast growth factor-23; lower concentrations of parathyroid hormone and 1,25-dihydroxyvitamin D; circulating vitamin D metabolite ratios suggesting lower CYP27B1 and higher CYP24A1 activity; higher urinary concentrations of calcium and phosphorus with higher urinary fractional excretion of phosphorus; and differences in vitamin D binding globulin haplotypes. Higher percent European ancestry was associated with higher 25-hydroxyvitamin D and lower parathyroid hormone concentrations among Black and Hispanic participants. Latent classes defined by vitamin D measurements reflected these patterns and differed significantly by race/ethnicity and ancestry.
CONCLUSIONS: Markers of vitamin D metabolism vary significantly by race/ethnicity, may serve to maintain bone and mineral homeostasis across ranges of 25-hydroxyvitamin D production, and be attributable, at least partly, to genetic ancestry. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  ancestry; mineral metabolism; parathyroid hormone; race; vitamin d

Mesh:

Substances:

Year:  2020        PMID: 32869845      PMCID: PMC7526733          DOI: 10.1210/clinem/dgaa612

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  69 in total

1.  Serum free and bio-available 25-hydroxyvitamin D correlate better with bone density than serum total 25-hydroxyvitamin D.

Authors:  Martin S Johnsen; Guri Grimnes; Yngve Figenschau; Peter A Torjesen; Bjørg Almås; Rolf Jorde
Journal:  Scand J Clin Lab Invest       Date:  2014-01-02       Impact factor: 1.713

2.  Estimating glomerular filtration rate from serum creatinine and cystatin C.

Authors:  Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey
Journal:  N Engl J Med       Date:  2012-07-05       Impact factor: 91.245

3.  Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease.

Authors:  A Levin; G L Bakris; M Molitch; M Smulders; J Tian; L A Williams; D L Andress
Journal:  Kidney Int       Date:  2006-11-08       Impact factor: 10.612

4.  Association of Degree of European Genetic Ancestry With Serum Vitamin D Levels in African Americans.

Authors:  Stephen A Haddad; Edward A Ruiz-Narváez; Yvette C Cozier; Hanna Gerlovin; Lynn Rosenberg; Julie R Palmer
Journal:  Am J Epidemiol       Date:  2018-07-01       Impact factor: 4.897

5.  Characterizing antibody cross-reactivity for immunoaffinity purification of analytes prior to multiplexed liquid chromatography-tandem mass spectrometry.

Authors:  Thomas J Laha; Frederick G Strathmann; Zhican Wang; Ian H de Boer; Kenneth E Thummel; Andrew N Hoofnagle
Journal:  Clin Chem       Date:  2012-09-11       Impact factor: 8.327

6.  Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.

Authors:  Takashi Shigematsu; Junichiro James Kazama; Takeyoshi Yamashita; Seiji Fukumoto; Tatsuo Hosoya; Fumitake Gejyo; Masafumi Fukagawa
Journal:  Am J Kidney Dis       Date:  2004-08       Impact factor: 8.860

7.  Evidence for alteration of the vitamin D-endocrine system in blacks.

Authors:  N H Bell; A Greene; S Epstein; M J Oexmann; S Shaw; J Shary
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

8.  25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III).

Authors:  Ian H de Boer; George N Ioannou; Bryan Kestenbaum; John D Brunzell; Noel S Weiss
Journal:  Am J Kidney Dis       Date:  2007-07       Impact factor: 8.860

9.  Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.

Authors:  Tobias Larsson; Ulf Nisbeth; Osten Ljunggren; Harald Jüppner; Kenneth B Jonsson
Journal:  Kidney Int       Date:  2003-12       Impact factor: 10.612

10.  Effects of Vitamin D2 Supplementation on Vitamin D3 Metabolism in Health and CKD.

Authors:  Zona Batacchi; Cassianne Robinson-Cohen; Andrew N Hoofnagle; Tamara Isakova; Bryan Kestenbaum; Kevin J Martin; Myles S Wolf; Ian H de Boer
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-02       Impact factor: 8.237

View more
  11 in total

1.  Clinical and biomarker modifiers of vitamin D treatment response: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Simon Hsu; David K Prince; Kayleen Williams; Norrina B Allen; Gregory L Burke; Andrew N Hoofnagle; Xiaohui Li; Kiang J Liu; Robyn L McClelland; Erin D Michos; Bruce M Psaty; Steven J Shea; Kenneth M Rice; Jerome I Rotter; David Siscovick; Russell P Tracy; Karol E Watson; Bryan R Kestenbaum; Ian H de Boer
Journal:  Am J Clin Nutr       Date:  2022-03-04       Impact factor: 7.045

2.  Serum 25-Hydroxyvitamin D is Associated With Bone Microarchitecture and Strength in a Multiracial Cohort of Young Adults.

Authors:  Margaret Garrahan; Sarah Gehman; Sara E Rudolph; Adam S Tenforde; Kathryn E Ackerman; Kristin L Popp; Mary L Bouxsein; Shivani Sahni
Journal:  J Clin Endocrinol Metab       Date:  2022-08-18       Impact factor: 6.134

3.  Genetic Variants Associated With Mineral Metabolism Traits in Chronic Kidney Disease.

Authors:  Marciana L Laster; Bryce Rowan; Hua-Chang Chen; Tae-Hwi Schwantes-An; Xin Sheng; Peter A Friedman; T Alp Ikizler; Janet S Sinshiemer; Joachim H Ix; Katalin Susztak; Ian H de Boer; Bryan Kestenbaum; Adriana Hung; Sharon M Moe; Farzana Perwad; Cassianne Robinson-Cohen
Journal:  J Clin Endocrinol Metab       Date:  2022-08-18       Impact factor: 6.134

4.  Vitamin D, skin filaggrin, allergic sensitization, and race.

Authors:  Elisabet Johansson; Jocelyn M Biagini; Lisa J Martin; Hua He; John W Kroner; Cassandra Almasri; Veronica Velasquez; Maud Sonzogni; Stanley B DeVore; Daniel Spagna; Brittany Grashel; Gurjit K Khurana Hershey
Journal:  Ann Allergy Asthma Immunol       Date:  2022-01-23       Impact factor: 6.248

5.  Evaluation of Adherence to Guideline-Based Bone Mineral Density Screening in Veterans with HIV.

Authors:  Christie G Turin; Naveed Khanjee; Katharine Breaux; Reina Armamento-Villareal; Maria C Rodriguez-Barradas; Eva H Clark
Journal:  AIDS Res Hum Retroviruses       Date:  2022-01-24       Impact factor: 1.723

6.  Low Vitamin D Status Is Associated with Increased Risk of Mortality in Korean Men and Adults with Hypertension: A Population-Based Cohort Study.

Authors:  Dahyun Park; Juhee Lee; Clara Yongjoo Park; Min-Jeong Shin
Journal:  Nutrients       Date:  2022-04-28       Impact factor: 6.706

7.  Validation of the 24,25-dihydroxyvitamin D3 to 25-hydroxyvitamin D3 ratio as a biomarker of 25-hydroxyvitamin D3 clearance.

Authors:  Simon Hsu; Leila R Zelnick; Yvonne S Lin; Cora M Best; Bryan R Kestenbaum; Kenneth E Thummel; Andrew N Hoofnagle; Ian H de Boer
Journal:  J Steroid Biochem Mol Biol       Date:  2021-12-22       Impact factor: 4.292

8.  Age-Dependent Associations Between 25-Hydroxy Vitamin D Levels and COPD Symptoms: Analysis of SPIROMICS.

Authors:  Robert M Burkes; David J Couper; Igor Z Barjaktarevic; Christopher B Cooper; Wassim W Labaki; Meilan K Han; Prescott G Woodruff; Stephen C Lazarus; Trisha M Parekh; Robert Paine; Alejandro P Comellas; Russell P Bowler; Laura R Loehr; Nirupama Putcha; Robert A Wise; Todd T Brown; M Bradley Drummond
Journal:  Chronic Obstr Pulm Dis       Date:  2021-04-27

Review 9.  Vitamin D and Its Role in the Lipid Metabolism and the Development of Atherosclerosis.

Authors:  Andrei Mihai Surdu; Oana Pînzariu; Dana-Mihaela Ciobanu; Alina-Gabriela Negru; Simona-Sorana Căinap; Cecilia Lazea; Daniela Iacob; George Săraci; Dacian Tirinescu; Ileana Monica Borda; Gabriel Cismaru
Journal:  Biomedicines       Date:  2021-02-09

10.  Association between serum vitamin D levels and Helicobacter pylori cytotoxic-associated gene A seropositivity: a cross-sectional study in US adults from NHANES III.

Authors:  Wei-Ming Kuang; Yu-Jie Ren; Xu Chen; Qi Luo; Weijing Chen; Huai-Geng Pan; Ru-Liu Li; Ling Hu
Journal:  BMJ Open       Date:  2022-04-13       Impact factor: 3.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.